Left ventricular assist devices (LVADs) improve survival and quality of life for patients with advanced heart failure but are associated with high rates of thromboembolic and hemorrhagic complications. Antithrombotic therapy is required following LVAD implantation, though practices vary. Identifying a therapeutic strategy that minimizes the risks of thromboembolic and hemorrhagic complications is critical to optimizing patient outcomes and is an area of active investigation. This paper reviews strategies for initiating and maintaining antithrombotic therapy in durable LVAD recipients, focusing on those with centrifugal-flow devices.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569275 | PMC |
| http://dx.doi.org/10.1007/s12055-022-01409-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Serum lipid profiling reveals characteristic lipid signatures associated with stroke in patients with leukoaraiosis.
Sci Rep
December 2024
Bao Feng Key Laboratory of Genetics and Metabolism, Beijing, China.
Many lipid biomarkers of stroke have been identified, but the lipid metabolism in elderly patients with leukoaraiosis remains poorly understood. This study aims to explore lipid metabolic processes in stroke among leukoaraiosis patients, which could provide valuable insights for guiding future antithrombotic therapy. In a cohort of 215 individuals undergoing MRI, 13 stroke patients were matched with controls, and 48 stroke patients with leukoaraiosis were matched with 40 leukoaraiosis patients.
View Article and Find Full Text PDFComparison of Single Antiplatelet Therapy and Dual Antiplatelet Therapy after Endovascular Therapy in Patients with Lower Extremity Artery Disease.
Ann Vasc Dis
December 2024
Division of Cardiology, Central Japan International Medical Center, Minokamo, Gifu, Japan.
Evidence for antithrombotic therapy after endovascular therapy (EVT) is limited. This retrospective, multicenter, observational study enrolled 732 consecutive patients with lower extremity artery disease who underwent EVT between January 2018 and December 2019. Overall, 570 patients who received single antiplatelet therapy (SAPT) and dual antiplatelet therapy (DAPT) were selected and divided into the SAPT (n = 189) and DAPT (n = 381) groups.
View Article and Find Full Text PDFImpact of Antithrombotic Drug Continuation on Postoperative Outcomes in Patients with Carpal Tunnel Syndrome: A Randomised, Open-Label, Parallel Group Trial.
J Hand Surg Asian Pac Vol
December 2024
Department of Human Enhancement and Hand Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Article Synopsis
- The study examined how continuing or stopping antithrombotic drugs affects postoperative outcomes in patients with carpal tunnel syndrome undergoing endoscopic release surgery.
- 65 patients were divided into two groups: those who maintained their antithrombotic therapy and those who suspended it, with various measures of outcomes assessed before and after surgery.
- Results showed that patients who temporarily stopped their antithrombotic medication reported significantly less symptom severity and swelling three months post-surgery, with no complications reported in either group.
Systematic review and meta-analysis of audits measuring antithrombotic therapy within forty-eight hours for ischemic stroke.
J Stroke Cerebrovasc Dis
December 2024
Stroke and Aging Research Group, Department of Medicine, Monash University, Melbourne, Australia. Electronic address:
Article Synopsis
- A meta-analysis showed that 81.1% of patients received antithrombotic therapy within 48 hours of ischemic stroke, indicating general compliance with treatment guidelines.
- There was no significant difference in therapy rates between low- to middle-income countries and high-income countries, nor between older and more recent studies.
- The study concluded that most countries still fall short of the standards set by North America's Get With The Guidelines program for early antiplatelet therapy.
Ischemic Stroke Prevention in Patients Atrial Fibrillation and a Recent Ischemic Stroke, TIA, or Intracranial Hemorrhage; a World Stroke Organisation (WSO) Scientific Statement.
Int J Stroke
December 2024
Division of Neurology, McMaster University, Hamilton, ON, Canada.
Background: Secondary stroke prevention in patients with atrial fibrillation (AF) is one of the fastest growing areas in the field of cerebrovascular diseases. This Scientific statement from the World Stroke Organization Brain & Heart Task Force provides a critical analysis of the strength of current evidence this topic, highlights areas of current controversy, identifies knowledge gaps, and proposes priorities for future research.
Methods: We select topics with the highest clinical relevance and perform a systematic search to answer specific practical questions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!